JAMA IM published meta-analysis on prostate cancer screening decision aids, conducted by CLUE WG and first-authored by Jarno Riikonen

Major guidelines recommend shared decision making for prostate cancer screening. We conducted a systematic review and meta-analysis of randomized trials to estimate the impact of decision aids in decisional outcomes related to screening.

Our meta-analysis in JAMA Internal Medicine calls for decision aids specifically targeted to promote shared decision-making.

Decision Aids for Prostate Cancer Screening Choice: A Systematic Review and Meta-Analysis.

To access the ARTICLE, click here: jamanetwork.com

To access the accompanying EDITORIAL, click here: jamanetwork.com

To access the accompanying PODCAST, click here:

To access wide coverage by MEDIA, please click the following links:

Clinical Urology and Epidemiology Working Group

Partners

University of Helsinki logo Imperial College London logo McMaster University logo

Main Sponsors

Academy of Finland logo HUS logo Jane and Aatos Erkko Foundation logo Sigrid Juselius Stiftelse logo

Projects

ROTBUS logo
Prostate Treatment Choice logo
Nocturia Reviews logo
MODULE logo
ISTHMUS logo
FINNO Study logo
FIND logo
AVATAR logo
APPEAL logo

CONTACT

Kari Tikkinen
Depts. of Urology and Public Health
University of Helsinki and Helsinki University Hospital
kari.tikkinen@gmail.com
@KariTikkinen